ZeroHarm Sciences raises $7.2M to take plant-based supplements global
What's the deal? Hyderabad-based nutrition startup ZeroHarm SciencesDealroom has a profile for this one. Try Dealroom → has raised ₹65 crore ($7.2 million) in an early-stage round led by Kotak Alternate Asset ManagersDealroom has a profile for this one. Try Dealroom → and Alkemi Growth CapitalDealroom has a profile for this one. Try Dealroom →. Kotak invested ₹40 crore through its Kotak Life Sciences Fund IDealroom has a profile for this one. Try Dealroom →, with Alkemi contributing ₹25 crore.
What's the endgame? Founded in 2020 by Sachin and Shweta Darbarwar, ZeroHarm makes 100% plant-based supplements using patented nano-formulation technology. It converts plant nutrients into nano-sized particles that, it says, improve bioavailability and allow controlled release at lower dosages.
The startup runs a vertically integrated supply chain: it sources medicinal plants from more than 10,000 farmers across Northeast India and the Himalayas, extracts raw materials at the Guwahati Biotech Park, and handles formulation and GMP-certified manufacturing in-house. Its 60-plus SKUs span diabetes management, heart health, immunity, gut health and oncology support, sold through its website, Amazon, Flipkart and quick-commerce channels.
Where's the money going? ZeroHarm plans to expand across India and enter the US, UK and Middle East, while scaling research and manufacturing. Part of the capital will fund its "Trust over Promise" platform, designed to demonstrate supplement efficacy through measurable health outcomes.
Why now? India's nutraceutical market is growing alongside rising health awareness and demand for preventive care. Peers including Elevate NowDealroom has a profile for this one. Try Dealroom → and EarthfulDealroom has a profile for this one. Try Dealroom → have also raised capital recently.
The signal: At $7.2 million, the round sits in the mid-tier of early-stage deals — a modest cheque for a company with 60-plus products and a claimed base of more than 300,000 customers. The bet is that vertical integration and a research-led pitch can differentiate a plant-based brand in a crowded, fast-growing wellness market.
Read more: pulse.d2cinsider.com
Image credit: Generated with Gemini
